WO2002036070A3 - Nouvelle chimiokine de poisson et procedes d'utilisation de celle-ci - Google Patents

Nouvelle chimiokine de poisson et procedes d'utilisation de celle-ci Download PDF

Info

Publication number
WO2002036070A3
WO2002036070A3 PCT/US2001/045366 US0145366W WO0236070A3 WO 2002036070 A3 WO2002036070 A3 WO 2002036070A3 US 0145366 W US0145366 W US 0145366W WO 0236070 A3 WO0236070 A3 WO 0236070A3
Authority
WO
WIPO (PCT)
Prior art keywords
chemokine
novel
chemokines
identifying
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/045366
Other languages
English (en)
Other versions
WO2002036070A2 (fr
Inventor
Roy S. Sundick
Lei Liu
Brian Dixon
Kazuhiro Fujiki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wayne State University
Original Assignee
Wayne State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wayne State University filed Critical Wayne State University
Priority to AU2002220047A priority Critical patent/AU2002220047A8/en
Priority to AU2002220047A priority patent/AU2002220047A1/en
Publication of WO2002036070A2 publication Critical patent/WO2002036070A2/fr
Anticipated expiration legal-status Critical
Publication of WO2002036070A3 publication Critical patent/WO2002036070A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne une nouvelle chimiokine, dorénavant chimiokine-2 ou CK-2, et notamment des modes de réalisation particuliers dérivés de poissons tels que la truite arc-en-ciel (Oncorhynchus mykiss). L'invention concerne de nouveaux polypeptides correspondant aux chimiokines CK-2, ainsi que des acides nucléiques codant pour une chimiokine CK-2 et des anticorps qui se lient spécifiquement à une chimiokine CK-2. L'invention concerne également des méthodes thérapeutiques pour utiliser les nouvelles chimiokines CK-2. Plus spécifiquement, l'invention concerne des compositions pharmaceutiques, telles que des vaccins, qui contiennent une chimiokine CK-2 et un immunogène. Ces compositions pharmaceutiques peuvent être administrées à un organisme pour augmenter ou activer une réponse immunitaire à cet immunogène. Dans un autre mode de réalisation, l'invention concerne également un procédé de criblage pour identifier et/ou isoler des gènes dont l'ARNm est rapidement dégradé dans une cellule, par identification et/ou isolation d'acides nucléiques (par exemple, à partir d'une bibliothèque d'ADNc) possédant au moins un motif de séquence reconnu par une endonucléase. Ces procédés de criblage sont particulièrement utiles pour identifier et/ou isoler des gènes codant pour de nouvelles chimiokines, cytokines ou oncogènes.
PCT/US2001/045366 2000-10-30 2001-10-30 Nouvelle chimiokine de poisson et procedes d'utilisation de celle-ci Ceased WO2002036070A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002220047A AU2002220047A8 (en) 2000-10-30 2001-10-30 Novel fish chemokine and methods for use
AU2002220047A AU2002220047A1 (en) 2000-10-30 2001-10-30 Novel fish chemokine and methods for use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24431500P 2000-10-30 2000-10-30
US60/244,315 2000-10-30

Publications (2)

Publication Number Publication Date
WO2002036070A2 WO2002036070A2 (fr) 2002-05-10
WO2002036070A3 true WO2002036070A3 (fr) 2012-01-12

Family

ID=22922237

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/045366 Ceased WO2002036070A2 (fr) 2000-10-30 2001-10-30 Nouvelle chimiokine de poisson et procedes d'utilisation de celle-ci

Country Status (2)

Country Link
AU (2) AU2002220047A1 (fr)
WO (1) WO2002036070A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654188A (en) * 1991-12-23 1997-08-05 Boehringer Ingelheim International Gmbh Neuroblastoma-associated regulator gene
US6359118B2 (en) * 1997-09-05 2002-03-19 Altus Biologies, Inc. Carbohydrate crosslinked glycoprotein crystals
US6448054B1 (en) * 1999-04-08 2002-09-10 The General Hospital Corporation Purposeful movement of human migratory cells away from an agent source

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654188A (en) * 1991-12-23 1997-08-05 Boehringer Ingelheim International Gmbh Neuroblastoma-associated regulator gene
US6359118B2 (en) * 1997-09-05 2002-03-19 Altus Biologies, Inc. Carbohydrate crosslinked glycoprotein crystals
US6448054B1 (en) * 1999-04-08 2002-09-10 The General Hospital Corporation Purposeful movement of human migratory cells away from an agent source

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LILJEQVIST ET AL., JOURNAL OF BIOTECHNOLOGY, vol. 73, 1999, pages 1 - 33 *
PARDIGOL ET AL., PROC. NATL, ACAD. SCI. USA, vol. 95, May 1998 (1998-05-01), pages 6308 - 6313 *
PARDIGOL ET AL., PROC. NATL. ACAD. SCI. USA., vol. 95, May 1998 (1998-05-01), pages 6308 - 6313 *

Also Published As

Publication number Publication date
WO2002036070A2 (fr) 2002-05-10
AU2002220047A1 (en) 2002-05-15
AU2002220047A8 (en) 2012-02-02

Similar Documents

Publication Publication Date Title
ATE315088T1 (de) Tumorassoziierte antigenderivate der mage-familie,nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
ZA9811501B (en) Method to enhance an immune response of nucleic acid vaccination.
CA2315274A1 (fr) Polypeptides a activite aminopeptidase, et acides nucleiques codant ces polypeptides
EP2650311A3 (fr) Séquences d'acides aminés dirigées contre des cytokines hétérodimériques et/ou leurs récepteurs et polypeptides les comprenant
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
AU7381098A (en) Polypeptides having prolyl pipeptidyl aminopeptidase activity and nucleic acids encoding same
EP1975172A3 (fr) Ligands et inhibiteurs d'acide nucléique TGFß à forte affinité
WO2001012659A3 (fr) Sequence d'adn humain
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
DK0981631T3 (da) Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme
HK1049185A1 (zh) 可改萤光蛋白
WO1997027276A3 (fr) Acides nucleiques codant des polypeptides presentant l'activite de la lipase d'absidia
WO2003056021A3 (fr) Compositions de represseurs de tetracycline modifies et procedes d'utilisation
WO2001040313A3 (fr) Proteines immunoregulatrices felines, molecules d'acide nucleique et leurs utilisations
AU2003304145A1 (en) Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
AR039846A1 (es) Molecula de acido nucleico que codifica un antigeno de muc-1, siendo dicha molecula capaz de producir una respuesta inmune in vivo
WO2002036070A3 (fr) Nouvelle chimiokine de poisson et procedes d'utilisation de celle-ci
WO1998018822A3 (fr) Nouvelles proteines humaines lim
WO2006000213A3 (fr) Peptides destines a inhiber l'interaction de la proteine kinase a et des proteines d'ancrage de la proteine kinase a
WO2005049793A3 (fr) Methodes et compositions destinees a des approches combinatoires pour la therapie genique du cancer
WO1998004585A3 (fr) Nouvel antigene macrophage humain
PL370854A1 (en) Ee3-protein family and corresponding dna sequences
WO2002077229A3 (fr) Nouveaux cofacteurs du recepteur alpha x du foie et techniques d'utilisation
WO1998018942A3 (fr) Nouvelles proteines humaines rab
AU2003265343A1 (en) Plant rna binding protein, encoding nucleic acids, and methods of use

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)